Sight Diagnostics

OverviewSuggest Edit

Sight Diagnostics is a medical device company, which has developed an artificial intelligence-driven platform for blood analysis and infectious disease diagnostics based on its proprietary machine-vision technology. The Company's technology allows healthcare providers to perform multiple tests on a single, easy-to-operate platform.

TypePrivate
Founded2011
HQTel Aviv, IL
Websitesightdx.com

Latest Updates

Employees (est.) (Oct 2020)97(+8%)
Cybersecurity ratingCMore

Key People/Management at Sight Diagnostics

Yossi Pollak

Yossi Pollak

Co-Founder and CEO
Assi Gol

Assi Gol

CCO
Yochay Eshel

Yochay Eshel

VP R&D
Doron Birger

Doron Birger

Chairman of the Board
Sarah Levy Schreier

Sarah Levy Schreier

CTO
Show more

Sight Diagnostics Office Locations

Sight Diagnostics has an office in Tel Aviv
Tel Aviv, IL (HQ)
48 Menahem Begin street
Show all (1)

Sight Diagnostics Financials and Metrics

Summary Metrics

Founding Date

2011

Sight Diagnostics total Funding

$133.8 m

Sight Diagnostics latest funding size

$71 m

Time since last funding

3 months ago

Sight Diagnostics investors

Sight Diagnostics's latest funding round in August 2020 was reported to be $71 m. In total, Sight Diagnostics has raised $133.8 m
Show all financial metrics

Sight Diagnostics Operating Metrics

Sight Diagnostics's Devices Sold was reported to be 600 k in Feb, 2019.
Feb, 2019

Countries

24

Devices Sold

600 k
Show all operating metrics

Sight Diagnostics Cybersecurity Score

Cybersecurity ratingPremium dataset

C

71/100

SecurityScorecard logo

Sight Diagnostics Online and Social Media Presence

Embed Graph

Sight Diagnostics News and Updates

Sysmex Challenger Sight Diagnostics Raises $71M As Capacity Soars 5-Fold

Sysmex revenues fell 12% while challenger Sight Diagnostics raised $71 million and quintupled manufacturing capacity. Is Sysmex losing market share?

Sight Diagnostics raises $71 million for blood-testing computer vision

Sight Diagnostics, a company developing a computer vision-based blood analyzer called Olo, has raised $71 million in venture capital.

Sight Diagnostics raises $71M Series D for its blood analyzer

Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch Disruptive Technologies, Longliv Ventures (which led its Series C round)and crowd-funding platform OurCrowd.…

Longliv Ventures Announces a $10m Strategic Investment in Sight Diagnostics Ltd

HERZELIYA, Israel, Feb. 28, 2019 /PRNewswire/ -- Longliv Ventures L.P. ("Longliv Ventures"), the consumer digital health fund, has announced the completion of a US $10 million strategic investment in Sight Diagnostics Ltd, a cutting-edge company that's transforming point-of-care...

Sight Diagnostics Frequently Asked Questions

  • When was Sight Diagnostics founded?

    Sight Diagnostics was founded in 2011.

  • Who are Sight Diagnostics key executives?

    Sight Diagnostics's key executives are Yossi Pollak, Assi Gol and Yochay Eshel.

  • How many employees does Sight Diagnostics have?

    Sight Diagnostics has 97 employees.

  • Who are Sight Diagnostics competitors?

    Competitors of Sight Diagnostics include Antelope Dx, Flux Biosciences and Sonivate Medical.

  • Where is Sight Diagnostics headquarters?

    Sight Diagnostics headquarters is located at 48 Menahem Begin street, Tel Aviv.

  • Where are Sight Diagnostics offices?

    Sight Diagnostics has an office in Tel Aviv.

  • How many offices does Sight Diagnostics have?

    Sight Diagnostics has 1 office.